Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (221-230 of 326) with videos related to

Pageof 33
Sort By:
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Urology|April 1, 1982
Radioimmunoassay versus counterimmune electrophoresis for measurement of serum prostatic acid phosphataseG L Wright, P F Schellhammer, M S Leffell, et al.
Cancer|September 25, 1990
Flow cytometric DNA analysis after immunoselection of bladder tumor cells with monoclonal antibody DU83.21G L Wright, J P Alexander, A M Konchuba, et al.
International Journal of Cancer|March 22, 1991
A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27G L Wright, M L Beckett, G B Lipford, et al.
Cancer|December 25, 1992
Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancerA M Konchuba, M C Clements, P F Schellhammer, et al.
Cancer Research|February 25, 1991
Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomasM L Beckett, G B Lipford, C L Haley, et al.
Urology|December 11, 2003
Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?Murat Bozlu, Ercüment Ulusoy, Erdal Doruk, et al.
Urology|May 1, 1990
Comparison of transrectal fine-needle aspiration cytology and core needle biopsy in diagnosis of prostate cancerD W Brenner, L E Ladaga, M B Fillion, et al.
Urology|September 8, 1998
Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomyK J Wojno, A R Vashi, P F Schellhammer, et al.
Urology|September 6, 2005
Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical techniqueDouglas W Soderdahl, Jose I Diaz, Danny M Rabah, et al.
Pageof 33

Showing results (221-230 of 326) with videos related to

Sort By:
Pageof 33
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Urology|April 1, 1982
Radioimmunoassay versus counterimmune electrophoresis for measurement of serum prostatic acid phosphataseG L Wright, P F Schellhammer, M S Leffell, et al.
Cancer|September 25, 1990
Flow cytometric DNA analysis after immunoselection of bladder tumor cells with monoclonal antibody DU83.21G L Wright, J P Alexander, A M Konchuba, et al.
International Journal of Cancer|March 22, 1991
A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27G L Wright, M L Beckett, G B Lipford, et al.
Cancer|December 25, 1992
Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancerA M Konchuba, M C Clements, P F Schellhammer, et al.
Cancer Research|February 25, 1991
Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomasM L Beckett, G B Lipford, C L Haley, et al.
Urology|December 11, 2003
Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?Murat Bozlu, Ercüment Ulusoy, Erdal Doruk, et al.
Urology|May 1, 1990
Comparison of transrectal fine-needle aspiration cytology and core needle biopsy in diagnosis of prostate cancerD W Brenner, L E Ladaga, M B Fillion, et al.
Urology|September 8, 1998
Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomyK J Wojno, A R Vashi, P F Schellhammer, et al.
Urology|September 6, 2005
Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical techniqueDouglas W Soderdahl, Jose I Diaz, Danny M Rabah, et al.
Pageof 33